← Back to headlines
Novo Nordisk Shares Plunge After Failed Trial, Prompting Investment Questions
Novo Nordisk's shares experienced a significant drop following the failure of a key clinical trial, leading investors to question whether this presents an opportunity to 'buy the dip'.
31 Jul, 21:15 — 31 Jul, 21:15
Sources
Showing 1 of 1 sources
